Premium
β‐Catenin mediates tumor‐induced immunosuppression by inhibiting cross‐priming of CD8 + T cells
Author(s) -
Liang Xinjun,
Fu Chunmei,
Cui Weiguo,
OberBlöbaum Julia L.,
Zahner Sonja P.,
Shrikant Protul A.,
Clausen Björn E.,
Flavell Richard A.,
Mellman Ira,
Jiang Aimin
Publication year - 2014
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1189/jlb.0613330
Subject(s) - priming (agriculture) , biology , cd8 , cytotoxic t cell , antigen , immunology , t cell , immunity , immune system , cross presentation , cancer research , mhc class i , in vitro , biochemistry , botany , germination
Tumors activate β‐catenin in DCs to suppress CD8 immunity by inhibiting cross‐priming; β‐catenin‐suppressed CD8 immunity could be rescued by enhancing cross‐priming.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom